Argenx (NASDAQ:ARGX) is one of the best biotech stocks to invest in now. On June 20, Argenx announced that the European ...

Redesigned mAb and antibody-based-like fragments 1,2,3,4,5,6,7 are poised to provide the next wave of antibody-based reagents for immunotherapy and in vivo medical imaging, with many already in ...

The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.

Dublin, Oct. 24, 2022 (GLOBE NEWSWIRE) -- The "Antibody Fragments Market Share, Size, Trends, Industry Analysis Report, By Specificity, By Type, By Therapy, By ...

Antibody fragments can be used to make antibody-drug conjugates. Here’s advice on how to produce the fragments themselves. Antibody-drug conjugates (ADCs) have great potential as targeted cancer ...

Antibody fragments have been used to aid structural analysis of complex macromolecules that are otherwise crystallization-resistant. However, there are issues such as stability, compatibility, and ...

Researchers at the Max Planck Institute for Molecular Genetics have developed a novel synthetic micropeptide termed the ...

ITHACA, N.Y. -- A novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicated gastric cancer in treated mice, a multi-institutional ...

These fragments, called variable domains, are the business end of any antibody — they act as the antibody’s “sensor” and can stick to parts of pathogens or toxins, whatever substance is ...

A new study from Karolinska Institutet shows how a small antibody fragment can block fertilization by targeting a key protein on the surface of the egg. This discovery brings a non-hormonal ...